Use of recombinant factor VIIa for bleeding in children with Glanzmann thrombasthenia.

Caglar K., Cetinkaya A., Aytac Ş. S., Gumruk F., Gurgey A.

Pediatric hematology and oncology, cilt.20, sa.6, ss.435-8, 2003 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 20 Sayı: 6
  • Basım Tarihi: 2003
  • Doi Numarası: 10.1080/08880010390220135
  • Dergi Adı: Pediatric hematology and oncology
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.435-8
  • Hacettepe Üniversitesi Adresli: Evet

Özet

Glanzmann thrombasthenia is a very rare inherited platelet function disorder in which bleeding may be extremely difficult to stop. Recombinant factor VIIa is one of the alternative treatments for bleeding. The authors report here their experience with the use of factor VIIa, which may be useful for arresting bleeding in Glazmann thrombasthenia.